Effects of the putative lithium mimetic ebselen on pilocarpine-induced neural activity

Nisha Singh, Florence Serres, Lilah Toker, Yeala Sade, Verity Blackburn, Ankita Sati Batra, Adolfo Saiardi, Galila Agam, Robert H. Belmaker, Trevor Sharp, Sridhar R. Vasudevan, Grant C. Churchill

Research output: Contribution to journalArticlepeer-review

4 Scopus citations


Lithium, commonly used to treat bipolar disorder, potentiates the ability of the muscarinic agonist pilocarpine to induce seizures in rodents. As this potentiation by lithium is reversed by the administration of myo-inositol, the potentiation may be mediated by inhibition of inositol monophosphatase (IMPase), a known target of lithium. Recently, we demonstrated that ebselen is a ‘lithium mimetic’ in regard to behaviours in both mice and man. Ebselen inhibits IMPase in vitro and lowers myo-inositol in vivo in the brains of mice and men, making ebselen the only known inhibitor of IMPase, other than lithium, that penetrates the blood-brain barrier. Our objective was to determine the effects of ebselen on sensitization to pilocarpine-induced seizures and neural activity. We administered ebselen at different doses and time intervals to mice, followed by injection of a sub-seizure dose of pilocarpine. We assessed seizure and neural activity by a subjective seizure rating scale, by monitoring tremors, and by induction of the immediate early gene c-fos. In contrast to lithium, ebselen did not potentiate the ability of pilocarpine to induce seizures. Unexpectedly, ebselen inhibited pilocarpine-induced tremor as well as pilocarpine-induced increases in c-fos mRNA levels. Both lithium and ebselen inhibit a common target, IMPase, but only lithium potentiates pilocarpine-induced seizures, consistent with their polypharmacology at diverse molecular targets. We conclude that ebselen does not potentiate pilocarpine-induced seizures and instead, reduces pilocarpine-mediated neural activation. This lack of potentiation of muscarinic sensitization may be one reason for the lack of side-effects observed with ebselen treatment clinically.

Original languageEnglish
Article number173377
JournalEuropean Journal of Pharmacology
StatePublished - 15 Sep 2020


  • Bipolar disorder
  • Ebselen
  • Inositol
  • Inositol monophosphatase
  • Lithium
  • Lithium-pilocarpine seizures

ASJC Scopus subject areas

  • Pharmacology


Dive into the research topics of 'Effects of the putative lithium mimetic ebselen on pilocarpine-induced neural activity'. Together they form a unique fingerprint.

Cite this